Abstract Dengue virus (DENV 1-4) represents a major emerging arthropod-borne pathogen.
All four DENV serotypes are prevalent in the (sub) tropical regions of the world and infect 50 …

The arthropod-borne diseases caused by dengue virus (DENV) are a major and emerging
problem of public health worldwide. Infection with DENV causes a series of clinical …

Severe dengue virus (DENV) infection results from viral replication and dysregulated host
immune response, which trigger massive cytokine production/cytokine storm. The result is …

Antibody-dependent enhancement of dengue virus (DENV) infection plays an important role
in the exacerbation of DENV-induced disease. To understand how antibodies influence the …

Since severe dengue virus (DENV) infection in humans associates with both high viral load
and massive cytokine production–referred to as “cytokine storm”, an ideal drug for treatment …

Human monocytes are susceptible to dengue virus (DV) infection through an FcR-
dependent pathway known as antibody-dependent enhancement (ADE). In this study …

Background Dengue Virus (DENV) is the most common mosquito-borne viral infection
worldwide. Important target cells during DENV infection are macrophages, monocytes, and …

Background. The production of type I interferon alpha/beta (IFN-α/β) is crucial to viral
clearance during dengue virus (DENV) infection; however, in vitro–infected dendritic cells …

The serum levels of beta interferon (IFN‐β) were evaluated in clinical samples taken in the
acute phase of dengue fever for 107 patients during the 2011 dengue outbreak in Yucatán …

Introducción: El dengue es la principal enfermedad viral transmitida a humanos por
artrópodos. Una de las características del cuadro clínico de la infección por el virus del …